Increasing incidence of thyroid cancer in the United States, JAMA, vol.295, p.16684987, 1973. ,
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, vol.26, p.26462967, 2015. ,
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989, Surgery, vol.114, p.8256208, 1993. ,
Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis, J Clin Endocrinol Metab, vol.90, p.16030160, 2005. ,
Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction, Thyroid, vol.14, p.15068628, 2004. ,
Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer, J Clin Endocrinol Metab, vol.100, p.25642591, 2015. ,
Extent of surgery affects survival for papillary thyroid cancer, Ann Surg, vol.246, p.17717441, 2007. ,
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients, J Clin Endocrinol Metab, vol.97, p.22344193, 2012. ,
The impact of age and gender on papillary thyroid cancer survival, J Clin Endocrinol Metab, vol.97, p.22496497, 2012. ,
Outcomes in patients with poorly differentiated thyroid carcinoma, J Clin Endocrinol Metab, vol.99, p.24512493, 2014. ,
Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome, Clin Endocrinol (Oxf), vol.63, p.15963067, 2005. ,
,
, Bull Cancer, vol.87, p.11084535, 2000.
Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer, J Clin Endocrinol Metab, vol.89, p.15292285, 2004. ,
Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients, Ann Surg, vol.260, p.25203876, 2014. ,
Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study, Eur J Surg Oncol, vol.43, p.27780677, 2017. ,
Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends, World J Surg Oncol, vol.14, p.27185169, 2016. ,
Stimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers, J Clin Endocrinol Metab, p.30785995, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02089771
Elevated serum thyroglobulin levels at the time of ablative radioactive iodine therapy indicate a worse prognosis in thyroid cancer: an Australian retrospective cohort study, J Laryngol Otol, vol.130, issue.4, p.27488338, 2016. ,
The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer, Am Surg, vol.71, p.16468507, 2005. ,
The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma, Surgery, vol.144, p.19041020, 2008. ,
Risk group stratification and prognostic factors in papillary carcinoma of thyroid, Ann Surg Oncol, vol.3, p.8915484, 1996. ,
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?, Thyroid, vol.27, p.28463585, 2017. ,
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer, Thyroid, vol.26, p.26914539, 2016. ,